GRADE guidelines: 8. Rating the quality of evidence-indirectness

被引:906
作者
Guyatt, Gordon H. [1 ,2 ]
Oxman, Andrew D. [3 ]
Kunz, Regina [4 ,5 ]
Woodcock, James [6 ]
Brozek, Jan
Helfand, Mark [7 ]
Alonso-Coello, Pablo [8 ,9 ]
Falck-Ytter, Yngve [10 ,11 ]
Jaeschke, Roman [2 ]
Vist, Gunn [3 ]
Akl, Elie A. [12 ]
Post, Piet N. [13 ]
Norris, Susan [14 ]
Meerpohl, Joerg [15 ,16 ]
Shukla, Vijay K. [17 ]
Nasser, Mona [18 ]
Schuenemann, Holger J. [2 ]
机构
[1] McMaster Univ, Dept Clin Epidemiol & Biostat, CLARITY Res Grp, W Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Dept Med, W Hamilton, ON L8N 3Z5, Canada
[3] Norwegian Knowledge Ctr Hlth Serv, N-0130 Oslo, Norway
[4] Univ Basel Hosp, Acad Swiss Insurance Med, CH-4031 Basel, Switzerland
[5] Univ Basel Hosp, Basel Inst Clin Epidemiol, CH-4031 Basel, Switzerland
[6] London Sch Hyg & Trop Med, London WC1, England
[7] Oregon Hlth & Sci Univ, Portland VA Med Ctr, Oregon Evidence Based Practice Ctr, Portland, OR 97201 USA
[8] Univ Autonoma Barcelona, Iberoamer Cochrane Ctr, Serv Epidemiol Clin & Salud Publ, Barcelona 08041, Spain
[9] Univ Autonoma Barcelona, Hosp St Pau, CIBERESP, Barcelona 08041, Spain
[10] Case Western Reserve Univ, Case & VA Med Ctr, Div Gastroenterol, Cleveland, OH 44106 USA
[11] Univ Oxford, Oxford, England
[12] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA
[13] Dutch Inst Healthcare Improvement CBO, Utrecht, Netherlands
[14] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA
[15] Univ Med Ctr Freiburg, Inst Med Biometry & Med Informat, German Cochrane Ctr, D-79104 Freiburg, Germany
[16] Univ Med Ctr Freiburg, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, D-79106 Freiburg, Germany
[17] CADTH, Ottawa, ON K1S 5S8, Canada
[18] Inst Qual & Efficiency Hlth Care IQWiG, Dept Hlth Informat, Cologne, Germany
关键词
GRADE; Quality of evidence; Indirectness; Indirect comparisons; Applicability; Generalizability; METAANALYSIS; THERAPY;
D O I
10.1016/j.jclinepi.2011.04.014
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Direct evidence comes from research that directly compares the interventions in which we are interested when applied to the populations in which we are interested and measures outcomes important to patients. Evidence can be indirect in one of four ways. First, patients may differ from those of interest (the term applicability is often used for this form of indirectness). Secondly, the intervention tested may differ from the intervention of interest. Decisions regarding indirectness of patients and interventions depend on an understanding of whether biological or social factors are sufficiently different that one might expect substantial differences in the magnitude of effect. Thirdly, outcomes may differ from those of primary interest-for instance, surrogate outcomes that are not themselves important, but measured in the presumption that changes in the surrogate reflect changes in an outcome important to patients. A fourth type of indirectness, conceptually different from the first three, occurs when clinicians must choose between interventions that have not been tested in head-to-head comparisons. Making comparisons between treatments under these circumstances requires specific statistical methods and will be rated down in quality one or two levels depending on the extent of differences between the patient populations, co-interventions, measurements of the outcome, and the methods of the trials of the candidate interventions. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:1303 / 1310
页数:8
相关论文
共 20 条
[1]   Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer -: A systematic review and meta-analysis [J].
Akl, Elie A. ;
Terrenato, Irene ;
Barba, Maddalena ;
Sperati, Francesca ;
Sempos, Elena V. ;
Muti, Paola ;
Cook, Deborah J. ;
Schuenemann, Holger J. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (12) :1261-1269
[2]  
[Anonymous], COCHRANE DATABASE SY
[3]  
Australian Government Department of Health and Ageing, 2009, REP SURR FIN OUTC WO
[4]  
Bucher H, 2008, USERS GUIDES MED LIT
[5]   The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials [J].
Bucher, HC ;
Guyatt, GH ;
Griffith, LE ;
Walter, SD .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (06) :683-691
[6]   Simultaneous comparison of multiple treatments: combining direct and indirect evidence [J].
Caldwell, DM ;
Ades, AE ;
Higgins, JPT .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7521) :897-900
[7]   Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis [J].
Cipriani, Andrea ;
Furukawa, Toshiaki A. ;
Salanti, Georgia ;
Geddes, John R. ;
Higgins, Julian P. T. ;
Churchill, Rachel ;
Watanabe, Norio ;
Nakagawa, Atsuo ;
Omori, Ichiro M. ;
McGuire, Hugh ;
Tansella, Michele ;
Barbui, Corrado .
LANCET, 2009, 373 (9665) :746-758
[8]   Statin therapy-evidence beyond lipid lowering contributing to plaque stability [J].
de Lorenzo, Ferruccio ;
Feher, Michael ;
Martin, Juliette ;
Collot-Teixeira, Sophie ;
Dotsenko, Olena ;
McGregor, John Louis .
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (28) :3385-3393
[9]   Statins research unfinished saga: desirability versus feasibility [J].
Fisman, Enrique Z. ;
Adler, Yehuda ;
Tenenbaum, Alexander .
CARDIOVASCULAR DIABETOLOGY, 2005, 4 (1)
[10]  
Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1